Sign up to save your podcasts
Or
Share The Lancet Oncology: November 14, 2012
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Oncology: November 14, 2012
Anticancer drugs: doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
11 ratings
Anticancer drugs: doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Oncology in conversation with
View all
Nature Podcast
757 Listeners
Culips Everyday English Podcast
1,012 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
507 Listeners
ASCO Daily News
61 Listeners
The Curbsiders Internal Medicine Podcast
3,338 Listeners
The Daily
111,156 Listeners
Up First from NPR
55,997 Listeners
ASCO Guidelines
45 Listeners
The Lancet Voice
23 Listeners
GU Cast | Urology Podcast
2 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet Respiratory Medicine in conversation with
1 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
eClinicalMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Lancet Regional Health in conversation with
0 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners